ALK-Positive Non-Small Cell Lung Cancer Latest Advances
Find the Latest Research About ALK-Positive Non-Small Cell Lung Cancer
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Lorlatinib and Amivantamab: A Paradigm Shift in EGFR and ALK Positive NSCLC, with More Effective but More Toxic Treatments Requiring a Well-Structured Shared Decision Making.
Journal: Oncology research
Published: September 08, 2025
Safety and Effectiveness of Brigatinib in Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Post-Marketing Surveillance Study.
Journal: Drugs - real world outcomes
Published: January 30, 2025
Early Onset Pulmonary Events and Management Strategies during the Treatment of ALK Positive NSCLC Patients with Brigatinib
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: May 15, 2023
Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC.
Journal: Thoracic cancer
Published: March 27, 2023
Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report.
Journal: Journal of medical case reports
Published: February 28, 2023
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practice.
Journal: Journal of thoracic disease
Published: May 21, 2022
Treatment of ALK Positive Non-small Cell Lung Cancer with Alectinib: A Case Report and Literature Review
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: September 15, 2021
An overview of alectinib hydrochloride as a treatment option for ALK positive non-small cell lung cancer.
Journal: Expert opinion on pharmacotherapy
Published: July 06, 2021
Design, synthesis and application of near-infrared fluorescence probe IR-780-Crizotinib in detection of ALK positive tumors.
Journal: Protein expression and purification
Published: March 13, 2021
Access to Tyrosine Kinase Inhibitors and Survival in Patients with Advanced EGFR+ and ALK+ Positive Non-small-cell Lung Cancer Treated in the Real-World.
Journal: Clinical lung cancer
Published: November 04, 2020
Alectinib Treatment of ALK Positive Non Small Cell Lung Cancer Patients with Brain Metastases: Our Clinical Experience.
Journal: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)
Published: October 04, 2020
Last Updated: 04/28/2026